Positive context积极背景
Stocks股票 / Health Care / TARS
Tarsus Pharmaceuticals Inc · Health Care
TARS US listed · USD美股 · 美元
Health Care
Russell 2000罗素2000
Speculative / unprofitable投机／未盈利
$75.69
-$0.27 · -0.36%
52w low52周低 $53.88high高 $92.87
Neutral — no clear edge中性 — 无明显优势
Setup almost complete — likely buy trigger in ~1–3 trading days if it closes back above its 10-day average.形态接近完成——若收盘重新站上 10 日均线，预计将在约 1–3 个交易日内出现买入触发。
As of 2026-09-28截至 2026-09-28
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-09-28
Momentum (RSI 14)动量（RSI 14）
49
Neutral zone中性区域
vs 50-day average相对50日均线
+7.2% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+10.2% above上方
Long trend up长期向上
Volatility波动率
93th percentile第93百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-11-0336
Mixed — beat 2 of last 4 quarters表现不稳 — 近 4 季中 2 季超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 -7.6%
Financials财务数据
fiscal years财年
Net margin净利率
-14.6%
FCF margin自由现金流利润率
-2.8%
Return on equity股本回报率 -19%
Clean稳健
Capital allocation资本配置
Share count change (1y)股数变化（1年）+11.0%
Debt coming due到期债务
SEC filingsSEC 文件Debt schedule not loaded yet.到期债务尚未加载。
This panel is still catching up to the SEC filings for this listing. Check back soon — nothing is being estimated in its place.本面板仍在同步该证券的 SEC 文件，请稍后再查看；此处不作任何估算替代。
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前，现金流情景暂不可用。
Capital-need coverage is not available for this issuer yet.该发行人的资本需求覆盖信息暂不可用。
Reported facts remain separate from the cash-flow scenario until identity and filing provenance are confirmed.在确认身份与报告来源之前，已披露事实与现金流情景保持分离。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
Golden cross on TARSTARS 金叉
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$11.7M net (0 buyers, 9 sellers)-$11.7M 净值（0 买家，9 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| RTW Investments | B | Holding持有 | 1.8% | 2026-06-30 |
Signal history信号历史
engine events引擎事件
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP. Buyers rejected the 2026-08-26 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all买入预备。买方拒绝了 2026-08-26 的低点（摆动低点已现），但价格尚未收复 10 日均线——第一项条件达成，并非全部
Sep 21, 2026
Golden cross on TARSTARS 金叉
The 50-day average crossed above the 200-day — a slow, widely-watched bullish trend signal. $77.46.50日均线上穿200日均线 — 一个滞后但广受关注的看多趋势信号。$77.46。
Sep 14, 2026
TARS daily MACD crossed downTARS 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $79.95.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$79.95。
Sep 2, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Sep 2, 2026
TARS made a new 52-week highTARS 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $82.76.价格创出52周新高 — 全市场关注的动量/趋势极值。$82.76。
Sep 2, 2026
TARS RSI reached overboughtTARS RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $82.76.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$82.76。
Aug 31, 2026
BOTTOMING → BUY ZONE筑底中 → 买入区
BUY买入
Aug 31, 2026
TARS StochRSI turned up from oversoldTARS StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $74.24.StochRSI重回20上方 — 下行动量趋缓的最早预警。$74.24。
Aug 28, 2026
UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP买入预备
Aug 27, 2026
BOTTOMING → UPTREND筑底中 → 上涨趋势
HOLD持有
Aug 26, 2026
UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP买入预备
Showing the last 15 of显示最近15条，共 157 signals条信号
Company profile公司档案
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -3.1% | +1.3% |
| 1 Month近1月 | +7.1% | +0.9% |
| 3 Months近3月 | +20.3% | +6.1% |
| 6 Months近6月 | +14.2% | +22.3% |
| Year to date年初至今 | -6.3% | +13.8% |
| 1 Year近1年 | +36.6% | +18.5% |
Trading information交易信息
Volatility rank波动率分位
93th pctile
EPS (trailing)每股收益
$-1.55
Off 52-week high距52周高点
-16.6%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$451M
Net income净利润
$-66M
Operating cash flow经营现金流
$-12M
Total assets总资产
$562M
Shareholder equity股东权益
$343M
Long-term debt长期负债
$72M
Shares outstanding总股本
0.04B
Returns & growth回报与增长
Return on equity股本回报率
-19.2%
Return on assets资产回报率
-11.7%
Debt / assets负债/资产
12.9%
Asset growth资产增速
+49.1%
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量：应计利润接近同业中位
- Capital discipline: assets +49.1% (aggressive expansion)资本纪律：资产 +49.1%（扩张激进）
- Balance sheet: leverage unremarkable资产负债表：杠杆水平一般
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
49
RSI (2-day)RSI（2日）
44
vs 20-day average相对20日均线
-4.2%
vs 50-day average相对50日均线
+7.2%
vs 200-day average相对200日均线
+10.2%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down动能向下
3-day3日线
momentum up动能向上
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range state波幅状态
expanding — range opening up扩张中 — 波幅放大
Range width percentile波幅宽度分位
59/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $-0.43 | $-0.21 | -104.8% |
| Mar 2026 | $-0.16 | $-0.46 | +65.2% |
| Dec 2025 | $-0.20 | $-0.19 | -5.3% |
| Sep 2025 | $-0.30 | $-0.35 | +14.3% |
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| RTW Investments | B | Holding持有 | 1.8% | $211M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
1
Buying vs selling买入vs卖出
0 : 0
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 12, 'holders_first': 2, 'holders_last': 1, 'holders_delta': -1, 'value_change_pct': 184.7, 'from_period': '2023-09-30', 'to_period': '2026-06-30', 'available_on': '2026-08-14', 'available_on_first': '2023-11-15', 'holders_series': [2, 2, 2, 2, 2, 2, 1, 1, 1, 1, 1, 1]}{'direction': 'distributing', 'n_quarters': 12, 'holders_first': 2, 'holders_last': 1, 'holders_delta': -1, 'value_change_pct': 184.7, 'from_period': '2023-09-30', 'to_period': '2026-06-30', 'available_on': '2026-08-14', 'available_on_first': '2023-11-15', 'holders_series': [2, 2, 2, 2, 2, 2, 1, 1, 1, 1, 1, 1]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$11.7M
Insider buyers vs sellers内部人买家vs卖家
0 : 9
Recent fund flows近期基金流向
SPDR S&P PharmaceuticalsSPDR S&P Pharmaceuticals
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。